Top Institutions in Hematology
The ranking is based on the institutions' national reputation in hematologic malignancies, their involvement in NIH/NCI programs, the strength of their clinical trials portfolio for transplant-ineligible patients, and their contributions to peer-reviewed research on treatment intensity.
-
#1
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber is a leader in defining dose-modified triplets for older/frail NDMM patients and has a robust clinical trials portfolio focused on optimizing treatment intensity.
Key Differentiators
- Hematology
- Oncology
-
#2
Mayo Clinic Comprehensive Cancer Center
Rochester, MN
Mayo Clinic is recognized for its risk-adapted frameworks and leadership in clinical trials that inform treatment intensity for transplant-ineligible NDMM patients.
Key Differentiators
- Hematology
- Oncology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
